What NAD⁺ is

Nicotinamide adenine dinucleotide (NAD⁺) is an essential pyridine-nucleotide cofactor present in every living cell. It exists in oxidized (NAD⁺) and reduced (NADH) forms and serves as the central electron carrier in glycolysis, the tricarboxylic acid cycle, fatty-acid β-oxidation, and oxidative phosphorylation. Beyond its redox role, NAD⁺ is a substrate for non-redox enzymes including the sirtuin family (SIRT1–SIRT7), poly-ADP-ribose polymerases (PARPs), and CD38/CD157 ectoenzymes, all of which consume NAD⁺ stoichiometrically. Reference-grade NAD⁺ powder is widely used as an assay reagent in biochemistry, cell biology, and aging research (Verdin, 2015 — PMID 26785480).

Mechanism of action

In its primary biochemical role, NAD⁺ accepts a hydride ion at the C4 position of its nicotinamide ring during oxidation of metabolic substrates, generating NADH that delivers electrons to mitochondrial Complex I. The NAD⁺/NADH ratio is a tightly regulated indicator of cellular redox state. As a sirtuin substrate, NAD⁺ is consumed when sirtuins cleave the glycosidic bond between nicotinamide and ADP-ribose to deacetylate target lysines on histones and metabolic enzymes; the products are nicotinamide and 2′-O-acetyl-ADP-ribose. PARPs consume NAD⁺ to construct poly-ADP-ribose chains on DNA-damage response proteins. Cellular NAD⁺ pools are maintained by salvage from nicotinamide via the NAMPT-catalyzed rate-limiting step, and by de novo synthesis from tryptophan via the kynurenine pathway. Cellular NAD⁺ declines with age in many tissues, a finding that has motivated extensive interest in precursor supplementation strategies (Verdin, 2015 — PMID 26785480).

Historical & structural context

NAD⁺ was discovered in 1906 by Harden and Young as a heat-stable factor required for yeast fermentation and was subsequently shown to be the central electron carrier in cellular metabolism. The molecule consists of two nucleotides — adenosine monophosphate and nicotinamide mononucleotide — joined by their phosphate groups via a pyrophosphate linkage. The non-redox role of NAD⁺ as a substrate for ADP-ribosyltransferases was recognized in the 1960s, and the discovery in 2000 that yeast Sir2 is an NAD⁺-dependent histone deacetylase opened a major new field linking cellular NAD⁺ status to chromatin regulation, metabolism, and aging.

Methodological considerations

Researchers working with NAD⁺ should account for (1) the inherent instability of the molecule in aqueous solution at neutral pH — fresh preparation or low-pH storage is required for accurate enzymatic assays; (2) the importance of nicotinamide product inhibition in sirtuin and PARP assays, which can mask catalytic activity; (3) cellular NAD⁺ pool measurements that require rapid quenching (acid extraction within seconds of harvest) to capture true intracellular concentrations; (4) interference from NADH and NADP⁺ in colorimetric and fluorometric NAD⁺ assays, often necessitating LC-MS quantification for high-confidence work; (5) compartmentalization of NAD⁺ between cytosol, mitochondria, and nucleus, with each pool maintained by distinct biosynthetic and transport machinery.

Research applications

NAD⁺ is used as a reagent and as a target of investigation in:

Mitochondrial respiration and Seahorse-type extracellular-flux assays.
Sirtuin enzymatic-activity profiling and inhibitor screening (Imai & Guarente, 2014 — PMID 24786309).
PARP activity and DNA-damage response assays.
NAD⁺/NADH ratio quantification in metabolic-flux studies.
Cellular senescence, aging, and longevity-pathway research (Rajman et al., 2018 — PMID 29514064).
CD38 hydrolase kinetic studies in immunometabolism.

Stability & handling notes

Lyophilized NAD⁺ powder is typically stable at −20 °C for 24 months protected from light and moisture. Reconstituted aqueous solutions are unstable at neutral and alkaline pH and should be prepared fresh, kept on ice, and used within hours; for longer-term storage, aliquots in 10 mM HCl or pH 5.5 buffer are preferred. NAD⁺ is hygroscopic and light-sensitive; vials should be equilibrated to room temperature before opening to minimize moisture condensation.

Common research dosing reference

In vitro enzymatic assays of sirtuins and PARPs typically use 100 μM to 1 mM NAD⁺ as substrate. Cell-culture supplementation studies investigating NAD⁺ uptake or boosting strategies have used 100 μM to 1 mM in media. Rodent intraperitoneal NAD⁺ administration in pre-clinical work has ranged from 50 to 500 mg/kg. These figures are reagent and research benchmarks only and have no implication for human dosing.

Quality & specifications

Reference-grade material is typically characterized by reverse-phase HPLC purity ≥98%, electrospray-ionization mass spectrometry (ESI-MS) confirming the expected monoisotopic mass, and quantitative amino-acid analysis where applicable. Cell-culture-grade lots additionally include endotoxin testing by Limulus amebocyte lysate (LAL) assay and bioburden screening. Each lot is shipped with a Certificate of Analysis itemizing purity, identity, residual solvents, water content (Karl Fischer), and acetate or trifluoroacetate counter-ion content where relevant. Investigators evaluating new lots should request raw chromatograms and mass spectra prior to incorporation into published work.

Pharmacology in context

NAD⁺ research intersects with a broader class of NAD-precursor and NAD-axis molecules that includes nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), nicotinamide, and nicotinic acid, each of which feeds into cellular NAD⁺ pools through distinct biosynthetic routes. Direct NAD⁺ supplementation differs mechanistically from precursor approaches, since intact NAD⁺ has limited cell-membrane permeability and is rapidly hydrolyzed in serum by CD38 and related ectoenzymes. Investigators using NAD⁺ as a reagent versus a supplementation tool should clearly distinguish these contexts, since enzymatic-assay reagent use does not generalize to whole-cell or in vivo bioavailability claims.

Reporting & reproducibility expectations

Publications using NAD⁺ should report: (a) supplier, lot, purity (typically 98%+ for biochemical-grade reagent), and verification by LC-MS or enzymatic assay; (b) reconstitution buffer, pH, and time-from-reconstitution to use; (c) for sirtuin and PARP enzymatic assays, appropriate substrate concentrations covering Km, product-inhibition controls, and consideration of nicotinamide accumulation; (d) for cellular NAD⁺ measurements, quenching method, extraction protocol, and analytical platform (LC-MS preferred); (e) full reagent storage history including freeze–thaw cycles. Many reproducibility issues in NAD-axis pharmacology trace to under-reporting of these methodological details.

Compliance & regulatory framing

This material is provided strictly for research and educational reference. The compound is supplied for in vitro investigation and laboratory characterization only and is not intended for human ingestion, injection, topical use, or any clinical application. Federal and state law treats research peptides as non-therapeutic chemicals; recipients are responsible for compliance with all applicable institutional, state, and federal regulations governing handling, storage, and disposal. Pricing, availability, and supply specifications are subject to change without notice. Request a Certificate of Analysis (COA), HPLC chromatograms, mass-spec verification, or compliance documentation from the Clinical Advisory Team for any specific lot.

Related research compounds

Investigators studying mitochondrial signaling and aging biology often co-reference MOTS-c 40 mg for mitochondrial-derived peptide signaling and GHK-Cu 100 mg for senescence-pathway gene-expression studies.

Sourcing & analytical verification

Reagent-grade NAD⁺ should be supplied with HPLC chromatograms documenting purity (typically ≥98% for biochemical research), mass-spec verification of the expected molecular weight (663.43 Da for the free acid, higher for various salt forms), and water-content quantification by Karl Fischer titration. The hydration state and counter-ion (free acid, disodium salt, lithium salt) affect both molecular weight and solubility characteristics, and protocols should specify which form was used. UV absorbance at 260 nm provides a convenient orthogonal concentration check (extinction coefficient approximately 18,000 M⁻¹cm⁻¹). For cell-culture applications, endotoxin testing is recommended given the sensitivity of metabolic and immunological readouts to LPS contamination.

References

References below are anchor PubMed citations. Readers are encouraged to verify each in the National Library of Medicine database before using as a research source.

For Research Use Only. Not for human or veterinary consumption, diagnostic procedures, or therapeutic use. Content is educational and non-promotional.

NAD+ 1000mg – Redox Cofactor for Laboratory Research